SunRegen Healthcare AG was recognized by JLABS of J&J
SunRegen JLABS recognition: SunRegen Healthcare AG was awarded a residency at JLABS@Shanghai. It is the third time SunRegen was recognized by pharma industry leader Johnson & Johnson. JLABS is a biopharmaceutical incubator set up by the pharmaceutical giant Johnson & Johnson, who uses the strictest standards to select innovative projects worldwide. SunRegen@JLABS: https://jnjinnovation.com/JLABSNavigator/company/SunRegen_Healthcare_AG SunRegen’s residency […]
Innosuisse Innovation Project Grant 2019
Innosuisse approved a grant for SunRegen Healthcare AG’s innovation project (Innosuisse funding application no. 35796.1 IP-LS). The total value of this project is CHF 1 million to facilitate the collaboration with EPFL and UZH This funding supports groundbreaking research and development in healthcare technologies. SunRegen Healthcare AG is committed to improving patient outcomes through innovative […]
BIO-Europe Copenhagen’s Startup Slam Winner 2018: SunRegen Healthcare AG
SunRegen Healthcare was announced as the winner of the BIO-Europe® 2018 Startup Slam competition, held in Copenhagen. Dr Yuhong Dong, Director and co-founder of SunRegen presented on how the company’s therapeutic a potentially transformative healthcare solution for neurodegenerative eye diseases. SunRegen receives a complimentary registration to BIO-Europe Spring® 2019 in Vienna, plus access to a […]
EC SME Instrument Phase 1 Grant
SunRegen has received funding from the European Union’s SME Instrument Phase 1 program under grant agreement No 827153. The EU SME Grant provides critical funding to innovative startups like SunRegen. It enables them to accelerate research. Moreover, it helps bring breakthrough healthcare solutions to market. SunRegen received this grant under the European Union’s SME Instrument […]
SunRegen Closed Seed Round Financing
SunRegen attracted the eyes of investors and won strong support from industry and academia scientists. On the first anniversary, SunRegen closed its seed round financing to move ahead on its promising project for the treatment of neurological disorders. The SunRegen seed financing provides essential resources to accelerate research and development in neurological therapeutics. Additionally, the […]
Swiss final of IMAGINE IF!
Congratulations to the IMAGINE IF! Global Top 20 Finalists! SunRegen was one of the top 20! SunRegen was awarded a special prize of 3 months’ free membership to the incubator StartLab at the life science park Biopôle, Lausanne, the first incubator dedicated to life sciences located in the Canton of Vaud. Full details about […]
Swiss CTI Approved Phase 3 CTI Coaching
In August, the SunRegen founder team presented their SBC003 project in the CTI coaching acceptance meeting. The jury acknowledged the high potential value in the market for treatments of neurodegenerative disorders. Swiss CTI decided to continue to support SunRegen and to offer professional coaching, executed by Dr. Andreas J. Schulze. The Swiss CTI Phase 3 […]
CTI Approved Innovation Grant
In order to encourage research collaboration with Swiss research groups, CTI provided an innovation grant to SunRegen to collaborate with the Brain Mind Institute (BMI) in École polytechnique fédérale de Lausanne (EPFL). The collaboration with EPFL will greatly expand the research capability of SunRegen. The SunRegen EPFL collaboration benefits from the CTI Innovation Grant, which […]
SunRegen Selected for Phase I of BaseLaunch Accelerator
SunRegen SBC003 project was accepted as a phase I project by BaseLaunch, which is a healthcare accelerator backed by Novartis, Pfizer, Johnson & Johnson, and Roche. The SunRegen BaseLaunch Phase I project gives the SBC003 team mentorship, funding, and access to a global healthcare network. Additionally, the program connects SunRegen with top pharmaceutical companies, including […]
CTI Offered CTI Coaching Phase 2
After a thorough evaluation of SunRegen’s business plan, Swiss Commission for Technology and Innovation (CTI) decided to offer CTI coaching phase 2 to SunRegen. CTI coach Dr. Andreas J. Schulze started to provide professional coaching support for SunRegen. The SunRegen CTI Coaching Phase 2 program supports the SBC003 team with professional mentorship, strategic guidance, and […]
